Phase 1CompletedINTERVENTIONAL
Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function
ClinicalTrials.gov · NCT01507389 · Registry updated: 2014-12-09
- Condition / research focus
- Diabetes; Diabetes Mellitus, Type 2
- Sponsor
- Novo Nordisk A/S
- Countries with listed sites
- Poland
- Registry dates and results
- Start: 2006-03. Completion: 2006-06 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- liraglutide (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Facility not reported
Warsaw, Poland
Site recruitment: Not reported